MéDICLEM

Active

Private limited companyfounded 20232 yrs activeLeopoldstadplein 8, 1040 Etterbeek, BelgiumKBO/BCE: BE 1004.016.712

The computed 12-month bankruptcy probability of MéDICLEM is 4.0% (elevated). The 2025 annual accounts show equity of €91k and a net result of €50k. The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.

Watch Print / PDF

Checked score

Score 2025

59 / 100

Fair

The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. An elevated bankruptcy probability caps the score. Every signal that weighs is under Signals.

Axes · tick = 2024

Profitability100=

Solvency100▲+5

Growth78

Track record82

Bankruptcy probability, 12 months

4.0% Elevated

0%0.5%1.5%4%10%≥ 25%

Credit up to €5k at 30 days only on tighter terms

Liquidity ample (current ratio 15.06 against 3.22 in 2024; short-term debt: 6.2% and cash: 89.2% of total assets), and 6.2% of the assets are financed with debt.

How do we compute the score and the probability?

Credit advice for your own amount and term

Signals

Seven signals. The signal on the left, the evidence on the right.

−lowers risk+raises risk○neutral

Young company

A young company has little track record yet and statistically fails more often than an established one.

KBO · incorporation date

Age against the risk zone

No NACE activity registered

No NACE activity is registered in the KBO, which is more common among companies that later fail.

KBO · activities

Higher-failure-rate region

In this region companies fail more often than in the rest of the country.

KBO · registered office

Annual accounts: healthy financial profile

The latest annual accounts show a healthy profile in solvency, result and liquidity.

NBB · annual accounts 2025

Solvency, return and age of the figures

Solvency

93.8%

Return on assets

51.5%

Age of the figures

9 mo

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 01-07-2026, 30 days ahead of the deadline.

NBB · 2 filings

Deviation from the deadline

2025

30 d early

2024

23 d early

← before the deadline after the deadline →

The next deadline is still running

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.

Companies Code · seven months

Position in the running window

17-09-2026 today31-12-2026 close31-07-2027 deadline

No strike-offs in the KBO publications

We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity

€91k▲ 117%

2024 · €42k

2024: €42k

2024 → 2025

Total assets

€97k▲ 62.2%

2024 · €59k

2024: €59k

2024 → 2025

Net result

€50k▲ 25.5%

2024 · €40k

2024: €40k

2024 → 2025

Working capital

€84k▲ 112%

2024 · €40k

2024: €40k

2024 → 2025

Multi-year overview

Every figure with its change against the year before

▲ rise ▼ fall

Line20242025Trend

Equity€42k-€91k▲ 117%

Operating result€51k-€63k▲ 24.8%

Net result€40k-€50k▲ 25.5%

Turnover and EBIT margin not published: the micro schema does not require them.

Result per fiscal year

Operating resultNet result

The operating result rises in 2025; 2025 is 25% above 2024.

Balance-sheet composition

2025 in colour, 2024 as the grey bar beneath

Assets €97k

93.0%

Fixed assets €7k▲ 211%

Current assets €90k▲ 56.5%

Equity and liabilities €97k

93.8%

Equity €91k▲ 117%

Debt €6k▼ 66.5%

The debt ratio falls from 29.9% to 6.2%. Equity is higher and debt is lower.

Key figures and ratios

2025 value · change against 2024

EBITDA

€68k▲

2024 · €51k

Cash flow

€55k▲

2024 · €40k

Solvency

93.8%▲

2024 · 70.1%

Current ratio

15.06▲

2024 · 3.22

Quick ratio

15.06▲

2024 · 3.22

Debt / equity

0.07▼

2024 · 0.43

ROE

54.8%▼

2024 · 94.9%

ROA

51.5%▼

2024 · 66.5%

Interest coverage

2281733.67▲

2024 · 847220.67

Debt

€6k▼

2024 · €18k

Debt ≤ 1 year

€6k▼

2024 · €18k

Income taxes

€13k▲

2024 · €11k

Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.

Filed annual accounts

As filed with the NBB · 2025 against 2024

Balance sheet Code20242025

Assets

Total assets20/58€59k€97k▲

Fixed assets21/28€2k€7k▲

Tangible fixed assets22/27€2k€7k▲

Furniture and vehicles24€2k€7k▲

Current assets29/58€57k€90k▲

Amounts receivable within one year40/41€75€3k▲

Trade receivables40€75-

Other amounts receivable41-€3k

Cash at bank and in hand54/58€56k€86k▲

Deferred charges and accrued income490/1€1k€910▼

Equity and liabilities

Total equity and liabilities10/49€59k€97k▲

Equity10/15€42k€91k▲

Contributions10/11€3k€3k=

Profit (loss) carried forward14€39k€88k▲

Amounts payable17/49€18k€6k▼

Amounts payable within one year42/48€18k€6k▼

Trade debts44€206€478▲

Suppliers440/4€206€478▲

Taxes, remuneration and social security45€11k€2k▼

Taxes450/3€11k€2k▼

Other amounts payable47/48€6k€4k▼

Income statement Code20242025

Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€304€5k▲

Other operating charges640/8-€204

Gross operating margin9900€51k€69k▲

Operating profit (loss)9901€51k€63k▲

Financial charges65/66B€0€0▼

Recurring financial charges65€0€0▼

Profit (loss) for the period before taxes9903€51k€63k▲

Income taxes67/77€11k€13k▲

Profit (loss) for the period9904€40k€50k▲

Profit (loss) for the period to be appropriated9905€40k€50k▲

Appropriation of the result

Profit (loss) to be appropriated9906€40k€88k▲

Profit (loss) brought forward from the previous period14P-€39k

Profit to be distributed694/7€859€833▼

Return on contributions (dividend)694€859€833▼

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

All 3Financial 1Filings 2

Next filing, fiscal year 2026, expected by 31-07-2027

2026

01-07

NBB filing Annual accounts filed

fiscal year 2025 · micro schema

2025

31-12

Financial Liquidity times 5current ratio 15.06

Current ratio from 3.22 to 15.06; short-term debt falls from €18k to €6k.

08-07

NBB filing Annual accounts filed

fiscal year 2024 · micro schema

Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors

1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.

Location & real-estate footprint

Registered office, Etterbeek · 1 establishment unit since 2023

establishment The establishment unit on the map

Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Leopoldstadplein 81040 Etterbeek

Ground area

1,094 m²

Building footprint

261 m²

Volume, LiDAR

2,413 m³

2 parcels, Brussels, Wallonia · tallest building 16.2 m, ±5 floors. Linked by address, not a title deed.

1 establishment unit

Rue Joséphine Rauscent 138, 1300 Wavre

General medical practice

since 20232.356.189.980

2 parcels

Wallonia 1 (50%) Brussels 1 (50%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
25055B0544/00M002	Wallonia	919 m²	1 · 112 m²	6.8 m · 2 fl.
21363B0484/00N004	Brussels	176 m²	1 · 149 m²	16.2 m · 5 fl.

Linked by address, not proof of ownership

Methodology

via registered seat: 1 · via establishment units: 1

2 of 2 parcels with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Company data · Crossroads Bank

Identification

Legal formPrivate limited company

Founded28-12-2023

Fiscal year end31-12

Sources

Crossroads Bank for EnterprisesNational Bank · 2 filingsAddress and cadastre registers

Data from official sources, last processed on 17-09-2026. Scores and ratios are computed by Checked and are not a credit decision.